ArticleJournal of ophthalmology2025
Evaluation of Visual Acuity, Postoperative Refractive Error, and Optical Aberrations in Patients With Previous Corneal Surgery and AcrySof IQ Vivity Intraocular Lens Implantation.
Article in Journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess the visual outcomes, refractive accuracy, and visual disturbances in patients with a history of myopic laser-assisted in situ keratomileusis (LASIK) who underwent cataract surgery with extended depth of focus intraocular lens (IOL). Methods: This prospective interventional study included 26 eyes of 13 patients who had previously undergone myopic LASIK surgery. All the participants underwent bilateral phacoemulsification and implantation of the AcrySof IQ Vivity IOL between May 2023 and March 2024. Inclusion criteria included patients > 50 years of age with corneal higher-order aberrations < 0.6 and coma < 0.4. Exclusion criteria included glaucoma, macular disease, retinal detachment, and corneal disease. Visual acuity examinations were performed 1 and 3 months postoperatively. Results: Before surgery, the mean uncorrected distance visual acuity (UDVA) was 0.3 ± 0.08 logMAR, and the mean corrected distance visual acuity (CDVA) was 0.1 ± 0.03 logMAR. At 3 months follow-up, significant improvements in UDVA (0.04 ± 0.05 logMAR), intermediate (0.1 ± 0.09), and near visual acuity (0.27 ± 0.1) were noted. Postoperatively, 65.4% of the eyes achieved refractive outcomes within ±0.5 D of emmetropia, and 92.3% were within ±1 D. Quality of Vision (QoV) scores revealed no considerable changes following surgery. Conclusion: The AcrySof IQ Vivity IOL demonstrated good uncorrected distance and intermediate visual outcomes in patients with prior myopic LASIK, along with functionally acceptable near vision and good refractive predictability. These findings support the use of this extended-depth-of-focus lens as a viable solution for presbyopia correction in postrefractive surgery patients, with minimal impact on visual disturbances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.